Organization Overview
Alternative names
aldesleukin (Proleukin) (1 trial)
bendamustine (treanda) (1 trial)
blueberry allergenic extract (1 trial)
bortezomib (velcade) (1 trial)
capecitabine (xeloda) (2 trials)
cisplatin (platinol) (1 trial)
dabrafenib (tafinlar) (1 trial)
docetaxel (taxotere) (2 trials)
fluorouracil (efudex) (1 trial)
fondaparinux sodium (arixtra) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Anemia (Phase 2)
Breakthrough Pain (Phase 4)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Small Cell (Phase 2)
Colonic Neoplasms (Phase 1)
Exanthema (Phase 1)
Glioblastoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, T-Cell (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Melanoma (Phase 2)
Mucositis (Phase 1)
Multiple Myeloma (Phase 2)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 2)
Osteomyelitis (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Sezary Syndrome (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomatitis (Phase 1)
Thrombocytopenia (Phase 2)
Uterine Cervical Neoplasms (Phase 2)